FDA approves Lilly's Inluriyo combo with Verzenio for breast cancer
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration has granted full approval to Inluriyo ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
